p53 mutant mice that display early ageing-associated phenotypes
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The p53 tumour suppressor is activated by numerous stressors to induce apoptosis, cell cycle arrest, or senescence. To study the biological effects of altered p53 function, we generated mice with a deletion mutation in the first six exons of the p53 gene that express a truncated RNA capable of encoding a carboxy-terminal p53 fragment. This mutation confers phenotypes consistent with activated p53 rather than inactivated p53. Mutant (p53+/m) mice exhibit enhanced resistance to spontaneous tumours compared with wild-type (p53+/+) littermates. As p53+/m mice age, they display an early onset of phenotypes associated with ageing. These include reduced longevity, osteoporosis, generalized organ atrophy and a diminished stress tolerance. A second line of transgenic mice containing a temperature-sensitive mutant allele of p53 also exhibits early ageing phenotypes. These data suggest that p53 has a role in regulating organismal ageing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, in mice, chronically active p53 both promotes cellular senescence and accelerates aging phenotypes [ 31 , 32 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [32]
In the citing paper
“Cells from these modified mice were more susceptible to both p53-mediated apoptosis (Tyner et al., 2002) and p53-mediated senescence (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Evidence for this idea comes from the phenotype of genetically modified mice in which p53 function was enhanced either by low-level expression of an artificially truncated p53 protein (Tyner et al., 2002; Maier et al., 2004) or modest overexpression of a naturally occurring short isoform (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Delayed wound healing has been used as measure to characterize the aging phenotype of skin (170).”
From Wound repair and regeneration: Mechanisms, signaling, and translation (2014) · cites this paper as [170]
In the citing paper
“p53 deficiency markedly attenuates the degenerative phenotypes associated with telomere dysfunction, whereas constitutively activated p53 accelerates ageing phenotypes15-18.”
From Telomere dysfunction induces metabolic and mitochondrial compromise (2011) · cites this paper as [18]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Self-citationManipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,245
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Increased bone formation in osteocalcin-deficient mice
Ducy, P., Desbois, C., Boyce, B., Pinero, G., Story, B., Dunstan, C., Smith, E., Bonadio, J., Goldstein, S., Gundberg, C., et al. (1996) · Nature · doi:10.1038/382448a0 · Cited by 1,725
Self-citationThe p66shc adaptor protein controls oxidative stress response and life span in mammals
Migliaccio, E., Giorgio, M., Mele, S., Pelicci, G., Reboldi, P., Pandolfi, P. P., Lanfrancone, L., & Pelicci, P. G. (1999) · Nature · doi:10.1038/46311 · Cited by 1,712
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Research works printed but not linked: 3
- Arking, R. Biology of Aging 2nd edn 153–250 (Sinauer, Sunderland, Massachusetts, 1998).
- Chuttani, A. & Gilchrest, B. A. in Handbook of Physiology, Section 11: Aging (ed. Masoro, E. J.) 309–324 (Oxford Univ. Press, New York, 1995).
- Muravchik, S. in Clinical Anesthesia 3rd edn (eds Barash, P. G., Cullen, B. F. & Stoelting, R. K.) 1125–1136 (Lippincott-Raven, Philadelphia, 1997).
Cited by
Items 101–200 of 1,000
Coordination and communication between the p53 and IGF-1–AKT–TOR signal transduction pathways
Levine, A. J., Feng, Z., Mak, T. W., You, H., & Jin, S. (2006) · Genes & Development · doi:10.1101/gad.1363206 · Cited by 321
“Designing drugs that break the p53–MDM2 com- plexes in cells and activate p53-mediated apoptosis in these cancer cells are awaiting a clinical trial (Vassilev et al. 2004).”
BackgroundOvariectomy induces oxidative stress and impairs bone antioxidant system in adult rats
Muthusami, S., Ramachandran, I., Muthusamy, B., Vasudevan, G., Prabhu, V., Subramaniam, V., Jagadeesan, A., & Narasimhan, S. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.04.014 · Cited by 320
Mechanisms that Regulate Stem Cell Aging and Life Span
Signer, R. A. J., & Morrison, S. J. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.001 · Cited by 320
Reactive Oxygen Species Stimulates Receptor Activator of NF-κB Ligand Expression in Osteoblast
Bai, X.-C., Lu, D., Liu, A.-L., Zhang, Z.-M., Li, X.-M., Zou, Z.-P., Zeng, W.-S., Cheng, B.-L., & Luo, S.-Q. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409332200 · Cited by 319
The First Approved Gene Therapy Product for Cancer Ad- p53 (Gendicine): 12 Years in the Clinic
Zhang, W.-W., Li, L., Li, D., Liu, J., Li, X., Li, W., Xu, X., Zhang, M. J., Chandler, L. A., Lin, H., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.218 · Cited by 318
“In 137–139”
p53, Oxidative Stress, and Aging
Liu, D., & Xu, Y. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3644 · Cited by 316
“In further support of the notion that oxidative stress is an inducer of aging, treatment with antioxidants can increase the life spans of various organisms and has a beneficial impact on aging-related diseases (6, 29, 38, 57, 114, 119).”
BackgroundInfluentialTiming of expression of the core clock gene Bmal1 influences its effects on aging and survival
Yang, G., Chen, L., Grant, G. R., Paschos, G., Song, W.-L., Musiek, E. S., Lee, V., McLoughlin, S. C., Grosser, T., Cotsarelis, G., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad3305 · Cited by 317
Ambrogini, E., Almeida, M., Martin-Millan, M., Paik, J.-H., DePinho, R. A., Han, L., Goellner, J., Weinstein, R. S., Jilka, R. L., O'Brien, C. A., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.12.009 · Cited by 309
“136 Cell Metabolism 11, 136–146, February 3, 2010 a2010 Elsevier In and signs of oxidative damage exhibit osteoporotic features (Tyner et al., 2002; De Boer et al., 2002).”
Bensaad, K., & Vousden, K. H. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.04.004 · Cited by 305
Short Telomeres, even in the Presence of Telomerase, Limit Tissue Renewal Capacity
Hao, L.-Y., Armanios, M., Strong, M. A., Karim, B., Feldser, D. M., Huso, D., & Greider, C. W. (2005) · Cell · doi:10.1016/j.cell.2005.11.020 · Cited by 302
“Since stem cell failure has been linked to aging (Tyner et al., 2002), subtle defects in telomere function that affect stem cell renewal potential may predispose to age-related disease.”
Backgroundp63 deficiency activates a program of cellular senescence and leads to accelerated aging
Keyes, W. M., Wu, Y., Vogel, H., Guo, X., Lowe, S. W., & Mills, A. A. (2005) · Genes & Development · doi:10.1101/gad.342305 · Cited by 298
The p53MH algorithm and its application in detecting p53-responsive genes
Hoh, J., Jin, S., Parrado, T., Edington, J., Levine, A. J., & Ott, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132268899 · Cited by 295
Cao, L., Li, W., Kim, S., Brodie, S. G., & Deng, C.-X. (2003) · Genes & Development · doi:10.1101/gad.1050003 · Cited by 293
“Recently, it was shown that activation of p53 results in premature aging in mouse (Tyner et al. 2002).”
BackgroundInfluentialMacrophage inhibitory cytokine‐1 (MIC‐1/GDF15): a new marker of all‐cause mortality
Wiklund, F. E., Bennet, A. M., Magnusson, P. K. E., Eriksson, U. K., Lindmark, F., Wu, L., Yaghoutyfam, N., Marquis, C. P., Stattin, P., Pedersen, N. L., et al. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00629.x · Cited by 288
“While p53 null mice have a significantly shortened lifespan (Tyner et al., 2002), cells from mice with genetic abnormalities that are associated with premature aging have increased levels of p53 (Rudolph et al.”
BackgroundRegulation of the p53 response and its relationship to cancer
Meek, D. W. (2015) · Biochemical Journal · doi:10.1042/bj20150517 · Cited by 288
A look behind the scenes: the risk and pathogenesis of primary osteoporosis
Hendrickx, G., Boudin, E., & Van Hul, W. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.48 · Cited by 285
DNA damage response and metabolic disease
Shimizu, I., Yoshida, Y., Suda, M., & Minamino, T. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.008 · Cited by 286
“Initial studies demonstrated that mice with one truncated p53 mutant allele and constitutive p53 activation develop premature aging, as well as showing resistance to cancer (Tyner et al., 2002) (Table 1).”
BackgroundThe p53 network: cellular and systemic DNA damage responses in cancer and aging
Vaddavalli, P. L., & Schumacher, B. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.02.010 · Cited by 279
The impact of acetylation and deacetylation on the p53 pathway
Brooks, C. L., & Gu, W. (2011) · Protein & Cell · doi:10.1007/s13238-011-1063-9 · Cited by 280
“Nevertheless, p53 has a clear functional role in cellular senescence and premature aging (Tyner et al., 2002), and SIRT1-mediated deacetylation may promote this phenotype and provide a regulatory link to cellular longevity.”
BackgroundAlmeida, M., Ambrogini, E., Han, L., Manolagas, S. C., & Jilka, R. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.023572 · Cited by 275
Nuclear genomic instability and aging
Niedernhofer, L. J., Gurkar, A. U., Wang, Y., Vijg, J., Hoeijmakers, J. H. J., & Robbins, P. D. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012239 · Cited by 275
Farnebo, M., Bykov, V. J. N., & Wiman, K. G. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.152 · Cited by 268
Osteoblast differentiation and skeletal development are regulated by Mdm2–p53 signaling
Lengner, C. J., Steinman, H. A., Gagnon, J., Smith, T. W., Henderson, J. E., Kream, B. E., Stein, G. S., Lian, J. B., & Jones, S. N. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200508130 · Cited by 265
“In contrast, a recently generated mouse model bearing a mutated p53 allele (m allele) that increased p53 activity in vitro displayed early aging-like phenotypes, including reduced mass of various internal organs, thinning of the dermis, hair loss, and osteoporosis (Tyner et al., 2002).”
BackgroundInfluentialSelf-citationp63 and p73 in human cancer: defining the network
DeYoung, M. P., & Ellisen, L. W. (2007) · Oncogene · doi:10.1038/sj.onc.1210337 · Cited by 266
“This phenotype was reminiscent of that induced following germline expression of a hypermorphic mutant p53 (Tyner et al., 2002), and was seemingly the opposite of the phenotype expected following loss of a tumor suppressor.”
BackgroundInfluentialFeng, Z., Hu, W., Teresky, A. K., Hernando, E., Cordon-Cardo, C., & Levine, A. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708043104 · Cited by 264
Vousden, K. H., & Prives, C. (2005) · Cell · doi:10.1016/j.cell.2004.12.027 · Cited by 259
“Tyner et al., 2002).”
Laminopathies and the long strange trip from basic cell biology to therapy
Worman, H. J., Fong, L. G., Muchir, A., & Young, S. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37679 · Cited by 257
Trade-Offs (and Constraints) in Organismal Biology
Garland, T., Downs, C. J., & Ives, A. R. (2022) · Physiological and Biochemical Zoology · doi:10.1086/717897 · Cited by 256
Bäckesjö, C.-M., Li, Y., Lindgren, U., & Haldosén, L.-A. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060415 · Cited by 256
“Interestingly, transgenic mice expressing mutated p53 with increased activity exhibited, among other phenotypes, osteoporosis.((27))”
BackgroundEmerging models and paradigms for stem cell ageing
Jones, D. L., & Rando, T. A. (2011) · Nature Cell Biology · doi:10.1038/ncb0511-506 · Cited by 256
Age to survive: DNA damage and aging
Schumacher, B., Garinis, G. A., & Hoeijmakers, J. H. J. (2008) · Trends in Genetics · doi:10.1016/j.tig.2007.11.004 · Cited by 254
Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism
Kuro-o, M. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.111 · Cited by 255
The circadian clock in cancer development and therapy
Fu, L., & Kettner, N. M. (2013) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-396971-2.00009-9 · Cited by 251
TAp63 Prevents Premature Aging by Promoting Adult Stem Cell Maintenance
Su, X., Paris, M., Gi, Y. J., Tsai, K. Y., Cho, M. S., Lin, Y.-L., Biernaskie, J. A., Sinha, S., Prives, C., Pevny, L. H., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.04.003 · Cited by 251
“Two mouse models expressing truncated p53 mutants display premature aging (Maier et al., 2004; Tyner et al., 2002), but other mouse models with elevated p53, the super p53 and mdm2puro/Δ7–12 mice (Garcia-Cao et al., 2002; Mendrysa et al., 2006), do not.”
BackgroundInfluentialSharpless, N. E., & DePinho, R. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00818-8 · Cited by 250
“Of course, anticancer therapies that do notevidence for this has been suggested by the generation induce p53 have long been sought in medical oncology,of a hyperfunctional allele of p53 in the mouse germline but the success rate for identification of such com-(Tyner et al., 2002).”
BackgroundImpact of aging on the biology of breast cancer
Benz, C. C. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.09.001 · Cited by 245
Obesity, DNA Damage, and Development of Obesity-Related Diseases
Włodarczyk, M., & Nowicka, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051146 · Cited by 242
“DNA damage-induced p53 activation was found to be involved in aging-related diseases, since mice with a p53 mutant allele associated with p53 activation developed premature aging and mice overexpressing naturally occurring truncated p53 isoform have a short lifespan [95,96].”
BackgroundMutations That Increase the Life Span of C. elegans Inhibit Tumor Growth
Pinkston, J. M., Garigan, D., Hansen, M., & Kenyon, C. (2006) · Science · doi:10.1126/science.1121908 · Cited by 242
A review and appraisal of the DNA damage theory of ageing
Freitas, A. A., & de Magalhães, J. P. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.05.001 · Cited by 240
The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging
Dumble, M., Moore, L., Chambers, S. M., Geiger, H., Van Zant, G., Goodell, M. A., & Donehower, L. A. (2007) · Blood · doi:10.1182/blood-2006-03-010413 · Cited by 241
“Mice: All p53 mutant mice used in this study were generated and reported previously by our laboratory.(12,23) The wild type and p53 deficient mice were produced by p53 heterozygote crossings and genotyped by Southern blot analysis, using a murine p53 exon 5-10 cDNA probe to genomic tail DNA cleaved with Bam HI as desc…”
BackgroundMethodInfluentialSelf-citationSenescence‐associated intrinsic mechanisms of osteoblast dysfunctions
Kassem, M., & Marie, P. J. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00669.x · Cited by 234
“A mouse model with enhanced activity of p53 revealed accelerated aging phenotype including bone loss (Tyner et al., 2002).”
BackgroundCellular Senescence: Molecular Mechanisms, In Vivo Significance, and Redox Considerations
Muller, M. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2104 · Cited by 238
Cancer and Aging: Two Tightly Interconnected Biological Processes
Berben, L., Floris, G., Wildiers, H., & Hatse, S. (2021) · Cancers · doi:10.3390/cancers13061400 · Cited by 235
“However, compared to the other strains, the mutant mice showed an early onset and enhanced aging phenotype, resulting in reduced lifespan [34].”
BackgroundInfluentialmdm2 Is Critical for Inhibition of p53 during Lymphopoiesis and the Response to Ionizing Irradiation
Mendrysa, S. M., McElwee, M. K., Michalowski, J., O'Leary, K. A., Young, K. M., & Perry, M. E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.462-473.2003 · Cited by 234
“Based on a recent report suggesting that elevated levels of p53 activity accelerate aging (56), one might speculate that drugs inhibiting p90 would cause aging.”
BackgroundKado, D. M., Huang, M., Karlamangla, A. S., Barrett‐Connor, E., & Greendale, G. A. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52458.x · Cited by 233
Deconstructing PML-induced premature senescence
Bischof, O. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf341 · Cited by 233
Senescent cells: SASPected drivers of age-related pathologies
Ovadya, Y., & Krizhanovsky, V. (2014) · Biogerontology · doi:10.1007/s10522-014-9529-9 · Cited by 232
“Consistent with this concept, p53 over-expression in mice revealed accelerated ageing phenotype including bone loss (Tyner et al. 2002), whereas telomerase over-expression in MSCs was found to preserve their potential to differentiate in vitro and to enhance bone formation in vivo (Shi et al. 2002;…”
Backgroundp53 alterations in human cancer: more questions than answers
Soussi, T. (2007) · Oncogene · doi:10.1038/sj.onc.1210280 · Cited by 232
“The p53þ /m mouse developed by Tyner et al. (2002) is also a good example of a possible dominant effect of truncated p53.”
BackgroundSobrino, T., Hurtado, O., Moro, M. A., Rodríguez-Yáñez, M., Castellanos, M., Brea, D., Moldes, O., Blanco, M., Arenillas, J. F., Leira, R., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.484386 · Cited by 232
Yaar, M., Eller, M. S., & Gilchrest, B. A. (2002) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1523-1747.2002.19636.x · Cited by 233
The SirT3 Divining Rod Points to Oxidative Stress
Bell, E. L., & Guarente, L. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.008 · Cited by 228
p53, ROS and senescence in the control of aging
Vigneron, A., & Vousden, K. H. (2010) · Aging · doi:10.18632/aging.100189 · Cited by 221
“In several mouse models, persistent low-level activation of p53, either through deregulated expression of p53 itself or in response to constitutive stress like DNA damage/telomere erosion, leads to premature aging [1,2].”
Backgroundp53 Activation in Adipocytes of Obese Mice
Yahagi, N., Shimano, H., Matsuzaka, T., Najima, Y., Sekiya, M., Nakagawa, Y., Ide, T., Tomita, S., Okazaki, H., Tamura, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302364200 · Cited by 220
Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes
Campisi, J. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00152-3 · Cited by 218
“Strikingly, it also accelerated aging in some tissues, and modestly decreased the life span (Tyner et al., 2002).”
BackgroundControl of metabolism by p53 – Cancer and beyond
Labuschagne, C. F., Zani, F., & Vousden, K. H. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.06.001 · Cited by 219
“While strong systemic activation of p53 is acutely deleterious to survival [164], more subtle but persistent increases in p53 activity reduced cancer development but lead to early aging [165, 166].”
BackgroundAn integrative view on sex differences in brain tumors
Sun, T., Plutynski, A., Ward, S., & Rubin, J. B. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1930-2 · Cited by 212
“spontaneous tumors [72].”
Changes in Regenerative Capacity through Lifespan
Yun, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025392 · Cited by 216
“compartment [77,78].”
Impaired ribosome biogenesis: mechanisms and relevance to cancer and aging
Turi, Z., Lacey, M., Mistrik, M., & Moudry, P. (2019) · Aging · doi:10.18632/aging.101922 · Cited by 215
“High and stable expression of p53 can decrease lifespan in mice and humans [298-300], therefore it is possible that upregulated p53 usually observed in ribosomopathies can also contribute to accelerated aging of those patients.”
BackgroundWnt and beyond Wnt: Multiple mechanisms control the transcriptional property of β-catenin
Jin, T., George Fantus, I., & Sun, J. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.04.014 · Cited by 215
Relevance of the p53–MDM2 axis to aging
Wu, D., & Prives, C. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.187 · Cited by 215
Min, D., Panoskaltsis-Mortari, A., Kuro-o, M., Holländer, G. A., Blazar, B. R., & Weinberg, K. I. (2007) · Blood · doi:10.1182/blood-2006-08-043794 · Cited by 214
Wang, Y., Probin, V., & Zhou, D. (2006) · Current Cancer Therapy Reviews · doi:10.2174/157339406777934717 · Cited by 213
Telomere Shortening Exposes Functions for the Mouse Werner and Bloom Syndrome Genes
Du, X., Shen, J., Kugan, N., Furth, E. E., Lombard, D. B., Cheung, C., Pak, S., Luo, G., Pignolo, R. J., DePinho, R. A., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8437-8446.2004 · Cited by 213
“Hair regrowth assays were done as described ( 53 ).”
MethodDoes caloric restriction extend life in wild mice?
Harper, J. M., Leathers, C. W., & Austad, S. N. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00236.x · Cited by 211
“Also, restriction much more severe than ours (i.e. up to 65% reduction from AL intake) has been reported to extend life dramatically in mice (Weindruch et al ., 1986).”
BackgroundTumor suppression and normal aging in mice with constitutively high p53 activity
Mendrysa, S. M., O'Leary, K. A., McElwee, M. K., Michalowski, J., Eisenman, R. N., Powell, D. A., & Perry, M. E. (2006) · Genes & Development · doi:10.1101/gad.1378506 · Cited by 210
“Next we investigated whether a reduction in Mdm2 elicited a number of aging-related phenotypes that have been ascribed to p53, including decreased body weight, reduced dermal thickness, reduced subcutaneous fat, and osteoporosis (Tyner et al. 2002; Maier et al. 2004).”
BackgroundInfluentialEvolutionary foundations for cancer biology
Aktipis, C. A., & Nesse, R. M. (2013) · Evolutionary Applications · doi:10.1111/eva.12034 · Cited by 209
“However, if the extra copies are constitutively expressed, mice show signs of premature aging (Tyner et al. 2002).”
BackgroundBiological functions of p53 isoforms through evolution: lessons from animal and cellular models
Marcel, V, Dichtel-Danjoy, M.-L., Sagne, C., Hafsi, H., Ma, D., Ortiz-Cuaran, S., Olivier, M., Hall, J., Mollereau, B., Hainaut, P., et al. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.120 · Cited by 210
Senescence-associated lncRNAs: senescence-associated long noncoding RNAs
Abdelmohsen, K., Panda, A., Kang, M.-J., Xu, J., Selimyan, R., Yoon, J.-H., Martindale, J. L., De, S., Wood, W. H., Becker, K. G., et al. (2013) · Aging Cell · doi:10.1111/acel.12115 · Cited by 208
“Since senescent cells accumulate in tissues as the organism ages, their metabolic behavior and their signature gene expression profile have been linked to a number of age-related physiologic and pathologic changes (Tyner et al., 2002; Baker et al., 2011).”
BackgroundVariation in the human TP53 gene affects old age survival and cancer mortality
van Heemst, D., Mooijaart, S. P., Beekman, M., Schreuder, J., de Craen, A. J. M., Brandt, B. W., Eline Slagboom, P., & Westendorp, R. G. J. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2004.10.001 · Cited by 206
“0.05. subjects died from general exhaustion and frailty, a human phenotype reminiscent of that described for the p53C/m mice (Tyner et al., 2002).”
BackgroundInfluentialBudanov, A. V. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3530 · Cited by 200
Narrative Review: Hyperkyphosis in Older Persons
Kado, D. M., Prenovost, K., & Crandall, C. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-5-200709040-00008 · Cited by 205
Sirtuins, Aging, and Metabolism
Guarente, L. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010629 · Cited by 202
The Immune System in the Elderly: Activation-Induced and Damage-Induced Apoptosis
Ginaldi, L., De Martinis, M., Monti, D., & Franceschi, C. (2004) · Immunologic Research · doi:10.1385/ir:30:1:081 · Cited by 202
“Tyner et al. showed that genetically mutated mice with activated p53 exhibit enhanced resistance to spontaneous tumors compared with wild-type, but concomitantly they display an early onset of phenotypes associated with aging (reduced longevity, osteoporosis, generalized organ atrophy, and a diminished stress toleranc…”
BackgroundBasic Biology of Skeletal Aging: Role of Stress Response Pathways
Almeida, M., & O'Brien, C. A. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glt079 · Cited by 201
Olsson, A., Manzl, C., Strasser, A., & Villunger, A. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402196 · Cited by 200
“p53 Enhanced p21 induction after g-rad, arrest not assessed Not assessed Not assessed Increased Tyner et al.(65)”
BackgroundInfluentialKim, K. S., Seu, Y. B., Baek, S.-H., Kim, M. J., Kim, K. J., Kim, J. H., & Kim, J.-R. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-03-0280 · Cited by 199
Chen, L., Yang, R., Qiao, W., Zhang, W., Chen, J., Mao, L., Goltzman, D., & Miao, D. (2019) · Aging Cell · doi:10.1111/acel.12951 · Cited by 196
RetractedThe role of stem cells in aging
Van Zant, G., & Liang, Y. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00088-2 · Cited by 195
“An additional mutation that underscores the close ties between tumorigenesis and stem cell regulation is a hypermorphic mutation in the tumor suppressor p53 gene (p53m) that almost completely suppresses carcinogenesis in the mutant mice but, surprisingly, produces a phenotype reminiscent of aging [196].”
BackgroundTargeting the p53 signaling pathway in cancer therapy – the promises, challenges and perils
Stegh, A. H. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.643299 · Cited by 194
“In addition, mice expressing a carboxy-terminal, constitutively active p53 mutant exhibited a premature aging phenotype, including organ atrophy, osteoporosis, and reduced life span [102].”
BackgroundActivated p53 suppresses the histone methyltransferase EZH2 gene
Tang, X., Milyavsky, M., Shats, I., Erez, N., Goldfinger, N., & Rotter, V. (2004) · Oncogene · doi:10.1038/sj.onc.1207706 · Cited by 194
“In addition, activation of p53 induces premature senescence and plays a role in the generation of early aging-associated phenotypes in mice (Sharpless and DePinho, 2002; Tyner et al., 2002).”
Background20 years studying p53 functions in genetically engineered mice
Donehower, L. A., & Lozano, G. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2731 · Cited by 168
Self-citationTelomeres, oxidative stress and inflammatory factors: partners in cellular senescence?
Correia-Melo, C., Hewitt, G., & Passos, J. F. (2014) · Longevity & Healthspan · doi:10.1186/2046-2395-3-1 · Cited by 194
“Mounting evidence indicates that activation of pathways involved in cellular senescence impacts on mammalian lifespan [17-19].”
BackgroundDNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age
Kim, H., Chang, J., Shao, L., Han, L., Iyer, S., Manolagas, S. C., O'Brien, C. A., Jilka, R. L., Zhou, D., & Almeida, M. (2017) · Aging Cell · doi:10.1111/acel.12597 · Cited by 192
“transgenic mice with global gain-of-function mutation of p53 rapidly accumulate senescent cells and exhibit accelerated aging phenotypes, including low bone mass (Tyner et al., 2002; Maier et al., 2004).”
BackgroundCell Death in Chondrocytes, Osteoblasts, and Osteocytes
Komori, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122045 · Cited by 176
“Mice with activated mutations in p53 exhibit osteopenia [86].”
BackgroundShimizu, I., Yoshida, Y., Katsuno, T., Tateno, K., Okada, S., Moriya, J., Yokoyama, M., Nojima, A., Ito, T., Zechner, R., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.006 · Cited by 190
“It has been reported that C aging is associated with an increase of the p53-mediated transcriptional activity (Edwards et al., 2007) and that slight constitutive overactivation of p53 is associated with premature aging in mice (Maier et al., 2004; Tyner et al., 2002).”
BackgroundMolecular bases of progeroid syndromes
Navarro, C. L., Cau, P., & Lévy, N. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl214 · Cited by 189
Effect of medicinal plants on wound healing
Budovsky, A., Yarmolinsky, L., & Ben‐Shabat, S. (2015) · Wound Repair and Regeneration · doi:10.1111/wrr.12274 · Cited by 188
Sun, L.-Q., Lee, D. W., Zhang, Q., Xiao, W., Raabe, E. H., Meeker, A., Miao, D., Huso, D. L., & Arceci, R. J. (2004) · Genes & Development · doi:10.1101/gad.1176104 · Cited by 186
“This physiological response appears to trigger growth inhibition via activation of tumor suppressor genes, such as p16, p19, p53, and p21 (Alcorta et al. 1996; Kiyono et al. 1998; Stein et al. 1999; Ramirez et al. 2001; Randle et al. 2001; Rheinwald et al. 2002; Schmitt et al. 2002; Tyner et al. 2002).”
BackgroundCancer and ageing: convergent and divergent mechanisms
Serrano, M., & Blasco, M. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2242 · Cited by 182
A Common Biological Mechanism in Cancer and Alzheimers Disease?
Behrens, M., Lendon, C., & Roe, C. (2009) · Current Alzheimer Research · doi:10.2174/156720509788486608 · Cited by 184
“Tyner et al [26] created transgenic mice with a p53-mutation that confers phenotypes consistent with an activated form of p53.”
Backgroundp53 regulates Period2 expression and the circadian clock
Miki, T., Matsumoto, T., Zhao, Z., & Lee, C. C. (2013) · Nature Communications · doi:10.1038/ncomms3444 · Cited by 181
“Previously, it had been observed that mice heterozygous for constitutively active p53 displayed an enhanced aging phenotype that included enhanced loss of soft tissues and development of spinal kyphosis 44 .”
Darwinian medicine: a case for cancer
Greaves, M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2071 · Cited by 180
FOXP1 controls mesenchymal stem cell commitment and senescence during skeletal aging
Li, H., Liu, P., Xu, S., Li, Y., Dekker, J. D., Li, B., Fan, Y., Zhang, Z., Hong, Y., Yang, G., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89511 · Cited by 180
“…arrest, is mainly controlled by the p16 INK4A /Rb and p19 ARF /p53 pathways (13, 14). p16 INK4A is required for the age-associated decline in function of a number of adult stem cells (15–18), including BM MSCs (19). p53 -Deficient mice display osteoporosis and other aging-related features (20).”
Nishikawa, K., Nakashima, T., Takeda, S., Isogai, M., Hamada, M., Kimura, A., Kodama, T., Yamaguchi, A., Owen, M. J., Takahashi, S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42528 · Cited by 180
A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer
Mello, S. S., Valente, L. J., Raj, N., Seoane, J. A., Flowers, B. M., McClendon, J., Bieging-Rolett, K. T., Lee, J., Ivanochko, D., Kozak, M. M., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.09.007 · Cited by 179
“Mice expressing either of two N-terminal deletion variants (p53 or p53) display premature aging, which is at least in part attributable to effects on gene expression (Maier et al., 2004; Tyner et al., 2002).”
Nucleolar Function in Lifespan Regulation
Tiku, V., & Antebi, A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.03.007 · Cited by 178
On the evolution of cellular senescence
Kowald, A., Passos, J. F., & Kirkwood, T. B. L. (2020) · Aging Cell · doi:10.1111/acel.13270 · Cited by 179
“However, there was some indication that boosting apoptosis resulted in faster aging by accelerating the age-related loss in tissue cellularity (Kirkwood, 2002; Tyner et al., 2002).”
BackgroundEarly aging–associated phenotypes in Bub3/Rae1 haploinsufficient mice
Baker, D. J., Jeganathan, K. B., Malureanu, L., Perez-Terzic, C., Terzic, A., & van Deursen, J. M. A. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200507081 · Cited by 175
“Reduced dermal thickness and subdermal adipose are characteristics of aged mice (de Boer et al., 2002; Tyner et al., 2002).”
BackgroundGene expression profiling of aging reveals activation of a p53-mediated transcriptional program
Edwards, M. G., Anderson, R. M., Yuan, M., Kendziorski, C. M., Weindruch, R., & Prolla, T. A. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-80 · Cited by 174
“Further support for the role of increased p53 activity contributing to aging process comes from transgenic studies in mice that express overactive p53 and also demonstrate accelerated aging [42,43].”
BackgroundReduced Mcm2 Expression Results in Severe Stem/Progenitor Cell Deficiency and Cancer
Pruitt, S. C., Bailey, K. J., & Freeland, A. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0483 · Cited by 172
Metadata
- Authors
- Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., Hee Park, S., Thompson, T., Karsenty, G., Bradley, A., & Donehower, L. A.
- Affiliations
- Baylor College of Medicine (US)
- University of Massachusetts Chan Medical School (US)
- Leibniz Institute of Virology (LIV) (DE)
- Wellcome Sanger Institute (GB)
- Corresponding author
- Donehower, Lawrence A.
- Venue
- Nature
- Published
- 2002-01
- Volume
- 415
- Issue
- 6867
- Pages
- 45-53
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2171317581
- Cited by
- 1,459
- References
- 42
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 17 · 2023: 41 · 2022: 30 · 2021: 45 · 2020: 36 · 2019: 37 · 2018: 45 · 2017: 49 · 2016: 52 · 2015: 52 · 2014: 60 · 2013: 64 · 2012: 69
- FWCI
- 27.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p53, aging, longevity, osteoporosis, organ atrophy, stress tolerance, transgenic mice, apoptosis, cellular senescence
- MeSH terms
- Adipose Tissue, Aging, Alleles, Animals, Body Weight, Bone and Bones, Cell Transformation, Neoplastic, Cells, Cultured, Exons, Female, Hair, Longevity, Male, Mice, Transgenic, Neoplasms, Organ Size, Osteoporosis, Phenotype, RNA, Messenger, Skin, Wound Healing, Genes, p53, Tumor Suppressor Protein p53, Sequence Deletion, Aging, Premature, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.